Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

URAT1&XO inhibitor 2

Selected Variant

HY-153972-01

Size: 5 mg

URAT1&XO inhibitor 2 (Compound BDEO) is a dual inhibitor of xanthine oxidase and URAT1, with IC50 of 3.3 μM for xanthine oxidase. URAT1&XO inhibitor 2 blocks uptake of uric acid in HEK293 cells expressing URAT1, with a Ki value of 0.145 μM. URAT1&XO inhibitor 2 decreases serum urate level and uric acid excretion in hyperuricemic mice. URAT1&XO inhibitor 2 can be used for research of hyperuricemia[1].

Product Specifications

CAS Number

1239488-96-0

UNSPSC

12352005

Target

URAT1; Xanthine Oxidase

Type

Reference compound

Related Pathways

Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease

Applications

Metabolism-protein/nucleotide metabolism

Field of Research

Metabolic Disease; Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/urat1-xo-inhibitor-2.html

Concentration

10mM

Purity

98.69

Solubility

DMSO : 200 mg/mL (ultrasonic)

Smiles

BrC(C=C1)=CC=C1C/C(C2=C(C=C(C=C2)O)O)=N\O

Molecular Formula

C14H12BrNO3

Molecular Weight

322.15

References & Citations

[1]Hu Q, et al. (E) -2- (4-bromophenyl) -1- (2, 4-dihydroxyphenyl) ethanone oxime is a potential therapeutic agent for treatment of hyperuricemia through its dual inhibitory effects on XOD and URAT1. Biomed Pharmacother. 2017 Feb;86:88-94.

Shipping Conditions

Blue Ice

Storage Conditions

-20°C, 3 years (Powder)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Available Sizes

Price

Sign In for Pricing

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog